Down-regulated claudin-5 expression in tumor vessels may serve as a potential marker for poor prognosis in hepato-cellular carcinoma (26) while increased claudin-5 expression is associated with aggressive behavior in serous ovarian adeno-carcinoma (27). This evidence concerns the gene CLDN5 and neoplasm.